Trinity Biotech | Eiendeler



Assets Endring Dato
Abbott USD 81.41B 7.06B 2024-12
Bayer EUR 110.85B 3.9B 2024-12
Bio-Rad Laboratories USD 9.36B 1.24B 2024-12
EDAP TMS EUR 79.04M 3.12M 2024-09
J&J USD 180.1B 1.82B 2024-12
Roche Holding CHF 101.8B 6.02B 2024-12
Siemens EUR 157.86B 10.04B 2024-12
Thermo Fisher Scientific USD 97.32B 3.04B 2024-12
Tosoh JPY 1.33T 93M 2024-12
Trinity Biotech USD 97.45M 3.09M 2024-09
Veracyte USD 1.3B 25.01M 2024-12



Trinity Biotech Eiendeler - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Mar 2025.